Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Vertab SR 240 mg Tablets - UK EMC Drug Approval Details

Approvals/UK EMC/Vertab SR 240 mg Tablets

Approved

STANDARD

Vertab SR 240 mg Tablets

Chiesi Limited🇬🇧 Electronic Medicines Compendium

Approval Date: N/A
Approval ID: 8a527bfa0b26e7c1
Company: Chiesi Limited
Type: Standard

Approval Details

Approval Id: 8a527bfa0b26e7c1
Drug Approval Emc Name: Vertab SR 240 mg Tablets
Drug Name: Vertab SR 240 mg Tablets
Company Name: Chiesi Limited
Company Address: Chiesi Limited, 333 Styal Road, Manchester, M22 5LG
Company Website: http://www.chiesi.uk.com
Company Telephone: +44 (0) 161 488 5555
Company Medical Info Direct Line: +44 (0)1748 827 271
Company Medical Info Email: medinfo.uk@chiesi.com
Legal Category: Prescription only medicine

Active Ingredients

Approved

Quick Info

Agency

UK EMC

Country

🇬🇧

Approval ID

8a527bfa0b26e7c1

Type

Standard

Back to UK EMC Approvals